Literature DB >> 9973457

Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.

M N Kweon1, K Fujihashi, Y Wakatsuki, T Koga, M Yamamoto, J R McGhee, H Kiyono.   

Abstract

CD40 ligand (CD40L) gene-disrupted (CD40L-/-) mice were employed to examine the role of costimulatory signals via CD40L-CD40 interactions in mucosally induced tolerance. CD40L-/- and control (CD40L+/+) mice of the same C57BL/6 x 129/J background were immunized orally with 25 mg of OVA before systemic challenge with OVA in CFA. While CD40L+/+ mice showed reductions in Ag-specific T cell responses including delayed-type hypersensitivity (DTH) and proliferative responses, CD40L-/- mice underwent normal T cell responses. Further, cytokine analysis of splenic CD4+ T cells showed that both Th1-type (e.g., IFN-gamma and IL-2) and Th2-type (e.g., IL-4, IL-5, IL-6, and IL-10) responses were maintained in CD40L-/- mice orally immunized with OVA, whereas these cytokine responses in CD40L+/+ mice were significantly reduced. In addition, splenic CD4+ T cells from CD40L-/- mice orally immunized with OVA provided B cell help in Ag-specific Ab-forming cells when the cells were cultured with naive B cells in the presence of Ag and CD40L-transfected cell lines. In contrast, an identical culture condition containing splenic CD4+ T cells from orally tolerized CD40L+/+ mice did not exhibit helper activity. Taken together, these findings indicate that CD40L and CD40 interactions are essential for the induction of systemic T cell unresponsiveness to orally administered Ag.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  CD40L in autoimmunity and mucosally induced tolerance.

Authors:  Mi-Na Kweon; Hiroshi Kiyono
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity.

Authors:  Arno Hänninen; Nathan R Martinez; Gayle M Davey; William R Heath; Leonard C Harrison
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Peyer's patches are required for oral tolerance to proteins.

Authors:  K Fujihashi; T Dohi; P D Rennert; M Yamamoto; T Koga; H Kiyono; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

Authors:  Arno Hanninen; Leonard C Harrison
Journal:  Rev Diabet Stud       Date:  2004-11-10

5.  Hock immunization: a humane alternative to mouse footpad injections.

Authors:  T Kamala
Journal:  J Immunol Methods       Date:  2007-08-28       Impact factor: 2.303

6.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Authors:  Caroline H Wallace; Bill X Wu; Mohammad Salem; Ephraim A Ansa-Addo; Alessandra Metelli; Shaoli Sun; Gary Gilkeson; Mark J Shlomchik; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2018-04-05

7.  Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses.

Authors:  Y Wang; Y Mei; S Bao; L Xu
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

8.  Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells.

Authors:  Yoshinobu Koguchi; Abigail C Buenafe; Timothy J Thauland; Jennifer L Gardell; Elizabeth R Bivins-Smith; David B Jacoby; Mark K Slifka; David C Parker
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 9.  Regulation of IgE-Mediated Food Allergy by IL-9 Producing Mucosal Mast Cells and Type 2 Innate Lymphoid Cells.

Authors:  Jee-Boong Lee
Journal:  Immune Netw       Date:  2016-08-23       Impact factor: 6.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.